Revolutionizing Chronic Disease Management: Fangzhou's AI-Driven Healthcare Solutions
Fangzhou Inc., a prominent provider of AI-driven Internet healthcare solutions, was recently honored at the 2026 Guangzhou Artificial Intelligence and Intelligent Autonomous Systems Innovation Development Promotion Conference for its innovative work in "AI + chronic disease services." The event, attended by various industry stakeholders, recognized Fangzhou's subsidiary, Guangzhou Fangzhou Information Technology Co., Ltd., as one of the "Most Promising Enterprises" in the 2025 Guangzhou Artificial Intelligence Innovation Development List. This acknowledgment highlights Fangzhou's commitment to leveraging AI technology to revolutionize chronic disease management and healthcare solutions.
Fangzhou has been actively expanding its "AI + H2H (Hospital-to-Home)" smart healthcare ecosystem, utilizing AI advancements to address the complexities of chronic disease management. By integrating AI technologies into online consultations, health management, and long-term follow-up services, Fangzhou aims to establish itself as a trusted partner for chronic disease patients, offering comprehensive care models focused on continuous support and patient engagement. The Company's proprietary XingShi Large Language Model plays a crucial role in enhancing healthcare services beyond traditional clinical settings, emphasizing the importance of personalized and continuous care for patients.
The Conference served as a vital platform for fostering collaboration and innovation within the AI and healthcare industries, bringing together key stakeholders to drive advancements in technology, industry practices, and talent development. Fangzhou remains committed to enhancing its AI technology capabilities, expanding access to chronic disease services through digital innovation, and contributing to the growth of China's AI healthcare sector in alignment with the broader Healthy China initiative. With a strong focus on precision medicine and tailored medical care, Fangzhou continues to lead the way in transforming healthcare delivery through AI-driven solutions.
Fangzhou Inc., a leading online chronic disease management platform in China, has established itself as a pioneer in AI-enabled healthcare solutions. With a vast user base and a network of healthcare professionals, Fangzhou is dedicated to providing personalized medical care and precision medicine services. For more information on Fangzhou's innovative healthcare solutions, visit their website.